spexcsp

Паклитаксел подавляет миграцию клеток злокачественной глиомы

Мастерство обучения гарантирует правильное использование средств индивидуальной защиты при моделировании клинических встреч с COVID-19

Введение: Правильное использование средств индивидуальной защиты (СИЗ) ограничивает передачу серьезных инфекционных заболеваний медицинским работникам, что критически важно в эпоху коронавирусной болезни 2019 г. (COVID-19).

Однако предыдущие исследования показали, что медицинские работники часто ошибаются при применении и снятии СИЗ. Цель этого исследования состояла в том, чтобы определить, улучшают ли основанное на моделировании, освоение навыков обучения с осознанной практикой правильное использование СИЗ врачами во время имитации клинического контакта с пациентом COVID-19.

Методы:
• Это было предварительное и последующее исследование, проведенное в отделении неотложной помощи крупной академической больницы третичного уровня с 31 марта по 8 апреля 2020 года. В нем приняли участие 117 субъектов, в том числе 56 преподавателей и 61 врач-ординатор.

Перед вмешательством все участники прошли обучение по требованию учебного заведения по использованию СИЗ с помощью онлайн-видео и дополнительных материалов.

• Участники выполнили предварительную оценку навыков с использованием контрольного списка из 21 пункта, в котором указаны шаги по правильному надеванию и снятию СИЗ. Ожидается, что участники получат минимальный проходной балл (MPS) в 100%, определенный группой экспертов с использованием методик установления стандартов Mastery Angoff и Patient Safety. Участники, которые встретились с MPS на предварительном тестировании, были освобождены от образовательного вмешательства.

• Тестирование проводилось до и после личной демонстрации правильной техники надевания и снятия и 20 минут сознательной практики. Первичным результатом было изменение оценок правильного использования СИЗ после нашего образовательного вмешательства.

Вторичные результаты включали различия в показателях успеваемости между преподавателями и врачами-резидентами, а также различия в показателях работы при надевании и снятии.

Результаты. Все участники имели средний балл до тестирования 73,1% (95% доверительный интервал [ДИ], 70,9-75,3%). Результаты предварительного тестирования преподавателей и резидентов были схожими (75,1% против 71,3%, p = 0,082).

Средние баллы за снятие предметов перед тестированием были ниже, чем баллы за надевание, у всех участников (65,8% против 82,8%, p <0,001). Баллы участников увеличились на 26,9% (95% ДИ разницы 24,7-29,1%, p <0,001) после нашего образовательного вмешательства, в результате чего все участники достигли 100% MPS.

Заключение: Вмешательство в овладение мастерством с осознанной практикой обеспечило правильное использование СИЗ субъектами врачей в симулированной клинической встрече с пациентом COVID-19. Необходимо дальнейшее изучение результатов трансляции.

spexcsp

spexcsp

Human anti-Human IL-4 mAb
MBS8576802-01mLAF610 0.1mL(AF610)
EUR 565
Human anti-Human IL-4 mAb
MBS8576802-01mLAF635 0.1mL(AF635)
EUR 565
Polyclonal Anti- human IL-4 Antibody
GWB-BBP010 0.1 mg Ask for price
human anti-human IL-4 mAb(12)
E4A09D04-12 50ug
EUR 255
Description: Available in various conjugation types.
human anti-human IL-4 mAb(52)
E4A09D04-52 50ug
EUR 255
Description: Available in various conjugation types.
human anti-human IL-4 mAb(C1)
E4A09D04-C1 50ug
EUR 255
Description: Available in various conjugation types.
Human anti-human IL-4 mAb (C1)
A09D04-C1 1 Each Ask for price
Human anti-human IL-4 mAb (D44)
A09D04-D44 1 Each Ask for price
Rat Anti Human Interleukin-4, IL-4, unconjugated
MBS396740-01mg 0.1mg
EUR 260
Rat Anti Human Interleukin-4, IL-4, unconjugated
MBS396740-5x01mg 5x0.1mg
EUR 1015
Rat Anti Human Interleukin-4, IL-4, unconjugated
MBS396742-01mg 0.1mg
EUR 260
Rat Anti Human Interleukin-4, IL-4, unconjugated
MBS396742-5x01mg 5x0.1mg
EUR 1015
Rat Anti Human Interleukin-4, IL-4, unconjugated
MBS396744-01mg 0.1mg
EUR 260
Rat Anti Human Interleukin-4, IL-4, unconjugated
MBS396744-5x01mg 5x0.1mg
EUR 1015
Anti-Human IL-4
GWB-BIG229 500ug Ask for price
Anti-Human IL-4
MBS550674-01mg 0.1mg
EUR 260
Anti-Human IL-4
MBS550674-02mg 0.2mg
EUR 335
Anti-Human IL-4
MBS550686-01mg 0.1mg
EUR 260
Anti-Human IL-4
MBS550686-02mg 0.2mg
EUR 335
Anti-Human IL-4
RH400020 100 µg Ask for price
Anti-Human IL-4
MC444020 0.5 mg Ask for price
Anti‐Human IL‐17A
E2790213 100ul
EUR 225
Description: Available in various conjugation types.
Human IL-4
GWB-CB2917 0.01 mg Ask for price
Human IL-4
gAP-0227 1mg
EUR 450
IL-4, Human
E34M006H 5 μg
EUR 155
Human IL-4
MBS691496-0002mg 0.002mg
EUR 225
Human IL-4
MBS691496-5x0002mg 5x0.002mg
EUR 725
Human IL-4
MBS691811-005mg 0.05mg
EUR 555
Human IL-4
MBS691811-5x005mg 5x0.05mg
EUR 2205
Human IL-4
MBS691915-001mg 0.01mg
EUR 265
Human IL-4
MBS691915-5x001mg 5x0.01mg
EUR 890
IL-4, Human
MBS8575163-0005mg 0.005mg
EUR 245
IL-4, Human
MBS8575163-5x0005mg 5x0.005mg
EUR 940
Human IL-4
HC40020 20 µg Ask for price
Human IL-4
300-154P-100ug 100 µg Ask for price
Human IL-4
300-154P-1mg 1 mg Ask for price
Human IL-4
300-154P-20ug 20 µg Ask for price
Human IL-4
300-154P-500ug 500 µg Ask for price
Human IL-4
300-154P-5ug 5 µg Ask for price
Human Interleukin-4 (IL-4) Antibody
32184-05111 150 ug
EUR 215
Anti-Human IL-4 Antibody
101-M05 500 µg
EUR 246.75
Description: Interleukin 4 (IL-4) is a pleiotropic cytokine produced by activated T cells, mast cells, and basophils. It was initially identified as a B cell differentiation factor (BCDF), as well as a B cell stimulatory factor (BSF1). IL-4 has since been shown to have multiple biological effects on hematopoietic and non-hematopoietic cells, including B and T cells, monocytes, macrophages, mast cells, myeloid and erythroid progenitors, fibroblasts, and endothelial cells. Rat, mouse and human IL-4 are species-specific in their activities.
Anti-Human IL-4 Antibody
101-M508 100 µg
EUR 399
Description: Interleukin 4 (IL-4) is a pleiotropic cytokine produced by activated T cells, mast cells, and basophils. It was initially identified as a B cell differentiation factor (BCDF), as well as a B cell stimulatory factor (BSF1). IL-4 has since been shown to have multiple biological effects on hematopoietic and non-hematopoietic cells, including B and T cells, monocytes, macrophages, mast cells, myeloid and erythroid progenitors, fibroblasts, and endothelial cells. Rat, mouse and human IL-4 are species-specific in their activities.
Anti-Human IL-4 Antibody
102-P34 100 µg
EUR 245.7
Description: Interleukin 4 (IL-4) is a pleiotropic cytokine produced by activated T cells, mast cells, and basophils. It was initially identified as a B cell differentiation factor (BCDF), as well as a B cell stimulatory factor (BSF1). IL-4 has since been shown to have multiple biological effects on hematopoietic and non-hematopoietic cells, including B and T cells, monocytes, macrophages, mast cells, myeloid and erythroid progenitors, fibroblasts, and endothelial cells. Rat, mouse and human IL-4 are species-specific in their activities.
Anti-human IL-4 antibody
STJ15100045 250 µg
EUR 403.2
Description: This monoclonal antibody enables sensitive and specific detection of human IL-4 in immunoassays such as ELISA and ELISpot.
Anti-human IL-4 antibody
STJ15100046 250 µg
EUR 440.4
Description: This monoclonal antibody enables sensitive and specific detection of human IL-4 in immunoassays such as ELISA and ELISpot.
Anti-Human IL-4 PE
MBS697227-100Tests 100Tests
EUR 360
Anti-Human IL-4 PE
MBS697227-25Tests 25Tests
EUR 215
Anti-Human IL-4 PE
MBS697227-5x100Tests 5x100Tests
EUR 1580
Anti-Human IL-4 PE
MBS697234-100Tests 100Tests
EUR 335
Anti-Human IL-4 PE
MBS697234-25Tests 25Tests
EUR 185
Anti-Human IL-4 PE
MBS697234-5x100Tests 5x100Tests
EUR 1475
PE anti-human IL-4
GT18087 25 Tests Ask for price
  • Applications: Intracellular Staining for Flow Cytometry
  • Reactivity: Human, Cross-Reactivity: Swine (Pig, Porcine), Rhesus
PE anti-human IL-4
GT18088 50 µg Ask for price
  • Applications: Intracellular Staining for Flow Cytometry
  • Reactivity: Human, Cross-Reactivity: Swine (Pig, Porcine), Rhesus
Anti-Human IL-4 APC
MBS697235-100Tests 100Tests
EUR 320
Anti-Human IL-4 APC
MBS697235-25Tests 25Tests
EUR 185
Anti-Human IL-4 APC
MBS697235-5x100Tests 5x100Tests
EUR 1395
APC anti-human IL-4
GT18090 100 Tests Ask for price
  • Applications: Intracellular Staining for Flow Cytometry
  • Reactivity: Human, Cross-Reactivity: Swine (Pig, Porcine), Rhesus
APC anti-human IL-4
GT18089 25 Tests Ask for price
  • Applications: Intracellular Staining for Flow Cytometry
  • Reactivity: Human, Cross-Reactivity: Swine (Pig, Porcine), Rhesus
FITC anti-human IL-4
GT18085 100 Tests Ask for price
  • Applications: Intracellular Staining for Flow Cytometry
  • Reactivity: Human, Cross-Reactivity: Swine (Pig, Porcine), Rhesus
FITC anti-human IL-4
GT18086 50 µg Ask for price
  • Applications: Intracellular Staining for Flow Cytometry
  • Reactivity: Human, Cross-Reactivity: Swine (Pig, Porcine), Rhesus
Mouse Anti-Human IL-4
MBS690917-05mg 0.5mg
EUR 525
Mouse Anti-Human IL-4
MBS690917-5x05mg 5x0.5mg
EUR 2080
Biotin anti-human IL-4
GT18083 50 µg Ask for price
  • Applications: ELISA Detection, ELISPOT Detection, Intracellular Staining for Flow Cytometry
  • Reactivity: Human, Cross-Reactivity: Swine (Pig, Porcine), Rhesus
Biotin anti-human IL-4
GT18084 500 µg Ask for price
  • Applications: ELISA Detection, ELISPOT Detection, Intracellular Staining for Flow Cytometry
  • Reactivity: Human, Cross-Reactivity: Swine (Pig, Porcine), Rhesus
Anti-Human IL-4 - Biotin
RH400020B 50 µg Ask for price
Human Interleukin-4 (IL-4)
1-CSB-EP011659HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10ug
  • 50ug
  • 100ug
  • 200ug
  • 500ug
  • 1MG
  • MW: 31 kDa
  • Buffer composition: Tris-based buffer with 50% glycerol.
Description: Recombinant Human Interleukin-4(IL-4) expressed in E.coli
Interleukin-4 (IL-4) Human
GWB-2A39E4 0.01 mg Ask for price
  • Interleukin-4 (IL-4) Human was previously known under catalogue number 10-251-407123 was previously known under catalogue number 10-251-407123
IL-4, Interleukin-4, human
RC212-15 5ug
EUR 125.26
  • Product category: Proteins/Recombinant Proteins/Cytokines
Interleukin-4 (IL-4), Human
SR106-0020 20 µg Ask for price
Interleukin-4 (IL-4), Human
SR106-0100 100 µg Ask for price
human anti-human IL-2 mAb
E409C12-h100 100μL
EUR 395
Description: Available in various conjugation types.
human anti-human IL-5 mAb
E409C14-h100 100μL
EUR 395
Description: Available in various conjugation types.
human anti-human IL-8 mAb
E409C16-h100 100μL
EUR 395
Description: Available in various conjugation types.
human anti-human IL-5 mAb
E4A09D05 50ug
EUR 255
Description: Available in various conjugation types.
Human anti-Human IL-2 mAb
MBS8576800-005mg 0.05mg
EUR 325
Human anti-Human IL-2 mAb
MBS8576800-01mLAF405L 0.1mL(AF405L)
EUR 565
Human anti-Human IL-2 mAb
MBS8576800-01mLAF405S 0.1mL(AF405S)
EUR 565
Human anti-Human IL-2 mAb
MBS8576800-01mLAF610 0.1mL(AF610)
EUR 565
Human anti-Human IL-2 mAb
MBS8576800-01mLAF635 0.1mL(AF635)
EUR 565
Human anti-Human IL-5 mAb
MBS8576804-005mg 0.05mg
EUR 325
Human anti-Human IL-5 mAb
MBS8576804-01mLAF405L 0.1mL(AF405L)
EUR 565
Human anti-Human IL-5 mAb
MBS8576804-01mLAF405S 0.1mL(AF405S)
EUR 565
Human anti-Human IL-5 mAb
MBS8576804-01mLAF610 0.1mL(AF610)
EUR 565
Human anti-Human IL-5 mAb
MBS8576804-01mLAF635 0.1mL(AF635)
EUR 565
Human anti-Human IL-8 mAb
MBS8576808-005mg 0.05mg
EUR 325
Human anti-Human IL-8 mAb
MBS8576808-01mLAF405L 0.1mL(AF405L)
EUR 565
Human anti-Human IL-8 mAb
MBS8576808-01mLAF405S 0.1mL(AF405S)
EUR 565
Human anti-Human IL-8 mAb
MBS8576808-01mLAF610 0.1mL(AF610)
EUR 565
Human anti-Human IL-8 mAb
MBS8576808-01mLAF635 0.1mL(AF635)
EUR 565
human anti-human IL-1β mAb
E409C11-h100 100μL
EUR 395
Description: Available in various conjugation types.
human anti-human IL-10 mAb
E409C17-h100 100μL
EUR 395
Description: Available in various conjugation types.
Human anti-Human IL-10 mAb
MBS8576810-005mg 0.05mg
EUR 325
Human anti-Human IL-10 mAb
MBS8576810-01mLAF405L 0.1mL(AF405L)
EUR 565
Human anti-Human IL-10 mAb
MBS8576810-01mLAF405S 0.1mL(AF405S)
EUR 565
Human anti-Human IL-10 mAb
MBS8576810-01mLAF610 0.1mL(AF610)
EUR 565
Human anti-Human IL-10 mAb
MBS8576810-01mLAF635 0.1mL(AF635)
EUR 565
human anti-human IL-17A mAb
E409C18-h100 100μL
EUR 276.5
Description: Inflammation Storm Antibodies
Human anti-Human IL-1beta mAb
MBS8576798-005mg 0.05mg
EUR 325
Human anti-Human IL-1beta mAb
MBS8576798-01mLAF405L 0.1mL(AF405L)
EUR 565
Human anti-Human IL-1beta mAb
MBS8576798-01mLAF405S 0.1mL(AF405S)
EUR 565
Human anti-Human IL-1beta mAb
MBS8576798-01mLAF610 0.1mL(AF610)
EUR 565
Human anti-Human IL-1beta mAb
MBS8576798-01mLAF635 0.1mL(AF635)
EUR 565
Human IL-4 (AF)
300-814P-100ug 100 µg Ask for price
Human IL-4 (AF)
300-814P-1mg 1 mg Ask for price
Human IL-4 (AF)
300-814P-20ug 20 µg Ask for price
Human IL-4 (AF)
300-814P-500ug 500 µg Ask for price
Human IL-4 (AF)
300-814P-5ug 5 µg Ask for price
rec IL-4 (human)
H-9630.0002 2.0µg
EUR 313.2
rec IL-4 (human)
H-9630.0010 10.0µg
EUR 1140
GMP Human IL-4
300-987P-050 50 µg Ask for price
GMP Human IL-4
300-987P-100 100 µg Ask for price
GMP Human IL-4
300-987P-1mg 1 mg Ask for price
human anti-human IL-12/IL-23 p40 mAb(3H2)
E4A09D33-3H2 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody
human anti-human IL-12/IL-23 p40 mAb(5N9)
E4A09D33-5N9 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody
Human anti-human IL-12/IL-23 p40 mAb (3H2)
A09D33-3H2 1 Each Ask for price
Human anti-human IL-12/IL-23 p40 mAb (5N9)
A09D33-5N9 1 Each Ask for price
IL 4 Human, Yeast
PT-A02945
  • Ask for price
  • Ask for price
  • Ask for price
  • 2 µg
  • 10 µg
  • 1 mg
human anti-human IL-12/IL-23 p40 mAb(1G11)
E4A09D33-1G11 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody
Human anti-human IL-12/IL-23 p40 mAb (1G11)
A09D33-1G11 1 Each Ask for price
Human IL-4 Protein
abx060798-20ug 20 ug
EUR 560.4
  • Shipped within 5-10 working days.
Human IL-4 Protein
E2PD201006 20ug
EUR 595
Human IL-4 Protein
MBS9718706-0005mg 0.005mg
EUR 135
Human IL-4 Protein
MBS9718706-002mg 0.02mg
EUR 285
Human IL-4 Protein
MBS9718706-01mg 0.1mg
EUR 720
Human IL-4 Protein
MBS9718706-1mg 1mg
EUR 3925
Human IL-4 Protein
MBS9718706-5x1mg 5x1mg
EUR 17610
Human IL-4 protein
MBS9719248-001mg 0.01mg
EUR 115
Human IL-4 protein
MBS9719248-005mg 0.05mg
EUR 225
Human IL-4 protein
MBS9719248-01mg 0.1mg
EUR 325
Human IL-4 protein
MBS9719248-1mg 1mg
EUR 2485
Human IL-4 protein
MBS9719248-5x1mg 5x1mg
EUR 11130
Human IL-4 protein
PRP100273-100ug 100 μg
EUR 1029
Description: Human IL-4 protein, expressed in E. coli
Human IL-4 protein
PRP100273-1mg 1 mg
EUR 7139
Description: Human IL-4 protein, expressed in E. coli
Human IL-4 protein
PRP100273-20ug 20 μg
EUR 509
Description: Human IL-4 protein, expressed in E. coli
Human IL-4 protein
PRP2017-100ug 100 μg
EUR 429
Description: Human IL-4 protein, expressed in HEK293 Cells
Human IL-4 protein
PRP2017-10ug 10 μg
EUR 59
Description: Human IL-4 protein, expressed in HEK293 Cells
Human IL-4 protein
PRP2017-1mg 1 mg
EUR 3739
Description: Human IL-4 protein, expressed in HEK293 Cells
Human IL-4 protein
PRP2017-50ug 50 μg
EUR 249
Description: Human IL-4 protein, expressed in HEK293 Cells
IL-4 Protein, Human
UA040026
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 5 µg
  • 10 µg
  • 50 µg
  • 100 µg
  • 500 µg
  • 1 mg
IL-4, human recombinant
4137-10 each
EUR 333.6
IL-4, human recombinant
4137-1000 each
EUR 4444.8
IL-4, human recombinant
4137-50 each
EUR 836.4
Recombinant Human IL-4
6486 5 µg
EUR 194
Recombinant Human IL-4
HEILP-0401 5ug Ask for price
Human IL-4, Recombinant
MBS319039-002mg 0.02mg
EUR 330
Human IL-4, Recombinant
MBS319039-5x002mg 5x0.02mg
EUR 1385
Recombinant Human IL-4
MBS258217-0005mg 0.005mg
EUR 305
Recombinant Human IL-4
MBS258217-5x0005mg 5x0.005mg
EUR 1210
Recombinant Human IL-4
MBS7609188-005mg 0.05mg
EUR 345
Recombinant Human IL-4
MBS7609188-02mg 0.2mg
EUR 635
Recombinant Human IL-4
MBS7609188-1mg 1mg
EUR 1800
Recombinant Human IL-4
MBS7609188-5x1mg 5x1mg
EUR 6955
Recombinant Human IL-4
MBS7614313-005mg 0.05mg
EUR 345
Recombinant Human IL-4
MBS7614313-02mg 0.2mg
EUR 635
Recombinant Human IL-4
MBS7614313-1mg 1mg
EUR 1800
Recombinant Human IL-4
MBS7614313-5x1mg 5x1mg
EUR 6955
Recombinant Human IL-4
PH2006-.01 10ug
EUR 224
Description: Peptides & Proteins|Recombinant Proteins
Recombinant Human IL-4
PH2006-.1 10X10ug
EUR 684.8
Description: Peptides & Proteins|Recombinant Proteins
Recombinant Human IL-4
P1121-.005 5ug
EUR 108.8
Description: Peptides & Proteins|Recombinant Proteins
Recombinant Human IL-4
P1121-.1 100ug
EUR 976
Description: Peptides & Proteins|Recombinant Proteins

Размышления врачей-интернов об их обучении использованию средств индивидуальной защиты

История вопроса: Текущая пандемия COVID-19 продемонстрировала, что средства индивидуальной защиты (СИЗ) необходимы для предотвращения заражения и передачи инфекционных заболеваний, однако их использование в клинических условиях часто не оптимально.

Обучение и образование важны для обеспечения и поддержания безопасного и эффективного использования СИЗ медицинскими интернами, но существующие методы часто неадекватны для обеспечения соответствующих знаний и навыков.

Целью этого исследования было изучить опыт выпускников медицинских вузов по использованию СИЗ и выявить возможности для улучшения образовательных и учебных программ с целью повышения профессиональной безопасности и безопасности пациентов.

Методы: это исследование было проведено в 2018 году в крупной клинической больнице третичного уровня в Сиднее, Австралия, для изучения собственного опыта использования СИЗ медицинскими стажерами в начале их стажировки.

Рефлексивные группы были собраны сразу после теоретического и практического обучения СИЗ, во время ориентации в больнице. Стенограммы записанных дискуссий были проанализированы с использованием тематического подхода, основанного на модели поведения COM-B (способность, возможность, мотивация – поведение).

Результаты: приняли участие 80% из 90 подходящих выпускников. Многие стажеры ранее не получали формального обучения специальным навыкам, необходимым для оптимального использования СИЗ, и выработали потенциально небезопасные привычки.

Их опыт студентов-медиков в клинических областях резко контрастировал с рекомендуемой практикой, преподаваемой в больницах, и повлиял на их способность культивировать правильное использование СИЗ.

Выводы: обучение в бакалавриате должно соответствовать передовой практике использования СИЗ и включать практическое обучение, включающее правильные и безопасные методы.

Прогностическая ценность сверхэкспрессии ферментов, связанных с метаболизмом жирных кислот, при плоскоклеточном раке головы и шеи

Перепрограммирование метаболизма подвижных жизненных сил, соответствующего метаболизму липидов, является индикатором плоскоклеточного рака вершины и шеи (SCCHN). Тем не менее, остается неясным, влияет ли экспрессия белка, связанная с окислением жирных кислот (FAO) на выживаемость в SCCHN.

Мы стремились проанализировать экспрессию ферментов, связанных с ФАО, и определить ее корреляцию с клинико-патологическими переменными у пациентов с SCCHN. Иммуногистохимическая оценка (ИГХ) экспрессии белка, связанного с ФАО, вместе с карнитин-пальмитоилтрансферазой 1 (СРТ1), ацил-КоА-дегидрогеназой и синтазой жирных кислот (FAS) была проведена с использованием тканевых микрочипов из 102 резецированных опухолей SCCHN.

Выражения были классифицированы в соответствии с оценками IHC, и была решена статистическая принадлежность к клинико-патологическим компонентам. Относительно высокой экспрессии длинноцепочечной ацил-КоА-дегидрогеназы (LCAD) была защитная функция от смерти, связанной с раком (скорректированное отношение рисков (HR), 0,2; 95% доверительный интервал (CI), 0,05-0,87) после ковариации корректирование.

Возраст и медицинская стадия оставались объективными предикторами выживаемости (скорректированный HR, 1,75; 95% ДИ, 1,22–2,49 для возраста; скорректированный HR, 14,33; 95% ДИ, 1,89-108,60 для стадии III / IV).
Сверхэкспрессия ацил-CoA дегидрогеназы со средней длиной цепи и FAS коррелировала с высшей стадией опухоли (T3 / T4); тем не менее, ни один из этих компонентов не был объективным предиктором выживаемости.

Было повышено количество ферментов, связанных с ФАО, и сверхэкспрессия LCAD оказала защитное влияние на общую выживаемость у пациентов с более сильным SCCHN. Экспрессия ферментов, связанных с ФАО, может потребовать прогноза по результатам выживаемости при SCCHN.

 

Паклитаксел подавляет миграцию клеток злокачественной глиомы CD133 + U251 за счет снижения экспрессии гликолитических ферментов.

• Жизнеспособное метаболическое перепрограммирование (EMR) позволяет перестраивать последовательность метаболических генов и белков, когда опухолевые клетки адаптируются к своему микроокружению.

EMR характеризуется модификациями метаболического образца и промежуточных продуктов метаболизма, чтобы удовлетворить потребности опухолевых клеток в его или ее злокачественном разрастании и инфильтративном прогрессе.

• В текущем исследовании изучалась функция паклитаксела в низких дозах (PTX) в изменении диапазонов экспрессии ключевых генов и белков в процессе гликолиза в клетках глиомы CD133 + U251 и изучались связанные механизмы регуляции движения на молекулярном уровне.

Иммуномагнитные шарики CD133 были использованы для злокачественных клеток глиомы CD133 + U251, которые затем были разделены прямо на группу, подвергшуюся вредному лечению, и экспериментальную группу, обработанную 1, 2, 4 или 8 мкМ PTX в течение 72 часов.

• Пакет для подсчета клеток-8 (CCK-8) использовался для измерения пролиферации клеток U251. РНК и белок были извлечены из клеток злокачественной глиомы во всех группах, чтобы наблюдать за изменениями в диапазонах экспрессии ключевых гликолитических ферментов, соответствующих переносчику глюкозы 1 (GLUT1), пируваткиназе M (PKM) и лактатдегидрогеназе A (LDHA), используя количественная ПЦР с обратной транскрипцией и вестерн-блоттинг.

Для количественной оценки результатов разрешения РТХ на клетках U251 были проведены анализы миграции через лунки. Клетки глиомы CD133 + U251 удалялись эффективно.

• Клетки CD1133 + имели лучшую цену пролиферации по сравнению с клетками CD1133-. В клетках CD1133 +, обработанных PTX, дозозависимая скидка в пределах диапазонов экспрессии важных гликолитических ферментов GLUT1, PKM и LDHA была замечена в каждом диапазоне мРНК и белка.

Разрешение PTX дополнительно ингибировало миграцию клеток. Различия между управляющими и экспериментальными группами были статистически значимыми (P <0,05).

• Поскольку гликолиз выполняет незаменимую функцию в пролиферации и миграции клеток глиомы, подобных стволовым, PTX может ингибировать прогрессирование опухолевых клеток путем подавления диапазонов экспрессии генов и белков гликолитических ферментов в клетках глиомы CD133 +.

 

Human Dkk-1

MBS692271-5x002mg 5x0.02mg
EUR 1325

Human DKK-1

HC67719 10 µg Ask for price

DKK-1 Protein, Human

UA040180
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 5 µg
  • 10 µg
  • 50 µg
  • 100 µg
  • 500 µg
  • 1 mg

Dkk-1 (Human) ELISA Kit

EKA52037-5x96T 5x96T Ask for price

Dkk-1 (Human) ELISA Kit

EKA52037-96T 96T
EUR 446.9

Human CellExp? DKK-1, Human Recombinant

7132-10 each
EUR 333.6

Human CellExp? DKK-1, Human Recombinant

7132-50 each
EUR 1358.4

Human Dkk-1 ELISA Kit

GWB-SKR221 96 Tests Ask for price

Human Dkk-1 ELISA KIT

E42EH-269 96T/48T
EUR 795

Human Dkk-1 ELISA Kit

E28L0566 96T
EUR 666.67

Human DKK-1 ELISA Kit

EK5390 96 tests
EUR 599
  • https://www.sabbiotech.com/g-138088-Human-DKK-1-ELISA-Kit-EK5390.html

DKK-1 ELISA KIT|Human

EF000090 96 Tests
EUR 826.8

Human Dkk-1 ELISA Kit

NR-E10156
  • Ask for price
  • Ask for price
  • 96 Tests
  • 96 Tests

Human DKK-1 ELISA kit

LF-EK50797 1×96T
EUR 777.6

Human Dkk-1 ELISA Kit

SEKH-0144
  • Ask for price
  • Ask for price
  • 48 Tests
  • 96 Tests

DKK-1 (HEK293-expressed), Human

HY-P7155A 50ug
EUR 1011.6

Human Dkk-3

MBS691794-0002mg 0.002mg
EUR 300

Human Dkk-3

MBS691794-001mg 0.01mg
EUR 450

Human Dkk-3

MBS691794-5x001mg 5x0.01mg
EUR 1725

Human Dkk-2

MBS692245-0002mg 0.002mg
EUR 300

Human Dkk-2

MBS692245-001mg 0.01mg
EUR 450

Human Dkk-2

MBS692245-5x001mg 5x0.01mg
EUR 1725

Human Dkk-2

MBS692272-0005mg 0.005mg
EUR 250

Human Dkk-2

MBS692272-002mg 0.02mg
EUR 360

Human Dkk-2

MBS692272-5x002mg 5x0.02mg
EUR 1325

Human DKK-3

HC51274 10 µg Ask for price

Human DKK-2

HC51277 10 µg Ask for price

Human Dkk-1 Recombinant Protein

200-013 20 µg
EUR 136.5
Description: DKK-1 is a member of the DKK protein family which also includes DKK-2, DKK-3 and DKK-4. DKK-1 was originally identified as a Xenopus head forming molecule that behaves as an antagonist for Wnt signaling. Subsequent studies have shown that DKK-1 and DKK-4 play an important regulatory role in the Wnt /β-catenin signaling pathway by forming inhibitory complexes with LDL receptor-related proteins 5 and 6 (LRP5 and LRP6), which are essential components of the Wnt/βcatenin signaling system. LPR5 and LPR6 are single-pass transmembrane proteins that appear to act as co-receptors for Wnt ligands involved in the Wnt/βcatenin signaling cascade. It has been suggested that by inhibiting Wnt/β-catenin signaling, which is essential for posterior patterning in vertebrates, DKK-1 permits anterior development. This notion is supported by the finding that mice deficient of DKK-1 expression lack head formation and die during embryogenesis. Recombinant human DKK-1 fused to a C terminal His-tag derived from E. coli is a 26 kDa protein containing 235 amino-acid residues.

Human Dkk-1 Recombinant Protein

200-013S 5 µg
EUR 92.4
Description: DKK-1 is a member of the DKK protein family which also includes DKK-2, DKK-3 and DKK-4. DKK-1 was originally identified as a Xenopus head forming molecule that behaves as an antagonist for Wnt signaling. Subsequent studies have shown that DKK-1 and DKK-4 play an important regulatory role in the Wnt /β-catenin signaling pathway by forming inhibitory complexes with LDL receptor-related proteins 5 and 6 (LRP5 and LRP6), which are essential components of the Wnt/βcatenin signaling system. LPR5 and LPR6 are single-pass transmembrane proteins that appear to act as co-receptors for Wnt ligands involved in the Wnt/βcatenin signaling cascade. It has been suggested that by inhibiting Wnt/β-catenin signaling, which is essential for posterior patterning in vertebrates, DKK-1 permits anterior development. This notion is supported by the finding that mice deficient of DKK-1 expression lack head formation and die during embryogenesis. Recombinant human DKK-1 fused to a C terminal His-tag derived from E. coli is a 26 kDa protein containing 235 amino-acid residues.

Human Dkk-1 Recombinant Protein

PROTO94907 Regular: 5ug
EUR 300
Description: Human Dkk-1 Recombinant Protein expressed in Baculovirus with His-tag. Sequence domain: 32-266aa. Application(s): SDS-PAGE. Endotoxin: < 1 EU per 1ug of protein (determined by LAL method).

Recombinant Human DKK-1 Protein

PROTO94907-3 10ug
EUR 380.4
Description: DKK-1 is a member of the DKK protein family which also includes DKK-2, DKK-3 and DKK-4. DKK-1 was originally identified as a Xenopus head forming molecule that behaves as an antagonist for Wnt signaling. Subsequent studies have shown that DKK-1 and DKK-4 play an important regulatory role in the Wnt /β-catenin signaling pathway by forming inhibitory complexes with LDL receptor-related proteins 5 and 6 (LRP5 and LRP6), which are essential components of the Wnt/βcatenin signaling system. LPR5 and LPR6 are single-pass transmembrane proteins that appear to act as co-receptors for Wnt ligands involved in the Wnt/βcatenin signaling cascade. It has been suggested that by inhibiting Wnt/β-catenin signaling, which is essential for posterior patterning in vertebrates, DKK-1 permits anterior development. This notion is supported by the finding that mice deficient of DKK-1 expression lack head formation and die during embryogenesis. Recombinant human DKK-1 expressed in human 293 cells is a 35-40 kDa glycoprotein containing 235 amino-acid residues.

Recombinant Human Dkk-1 Protein

RP01343 100μg
EUR 162.96
  • Members of the dickkopf-related protein family (DKK-1, -2, -3, and -4) are secreted proteins with two cysteine-rich domains separated by a linker region. And DKK1 takes part in embryonic development through its inhibition of the WNT signaling pathway
  • Show more

human Dkk-1 Recombinant Protein

100-407 10 µg
EUR 196.35
Description: DKK-1 is a member of the DKK protein family which also includes DKK-2, DKK-3 and DKK-4. DKK-1 was originally identified as a Xenopus head forming molecule that behaves as an antagonist for Wnt signaling. Subsequent studies have shown that DKK-1 and DKK-4 play an important regulatory role in the Wnt /β-catenin signaling pathway by forming inhibitory complexes with LDL receptor-related proteins 5 and 6 (LRP5 and LRP6), which are essential components of the Wnt/βcatenin signaling system. LPR5 and LPR6 are single-pass transmembrane proteins that appear to act as co-receptors for Wnt ligands involved in the Wnt/βcatenin signaling cascade. It has been suggested that by inhibiting Wnt/β-catenin signaling, which is essential for posterior patterning in vertebrates, DKK-1 permits anterior development. This notion is supported by the finding that mice deficient of DKK-1 expression lack head formation and die during embryogenesis. Recombinant human DKK-1 expressed in human 293 cells is a 35-40 kDa glycoprotein containing 235 amino-acid residues.

human Dkk-1 Recombinant Protein

100-407S 2 µg
EUR 92.4
Description: DKK-1 is a member of the DKK protein family which also includes DKK-2, DKK-3 and DKK-4. DKK-1 was originally identified as a Xenopus head forming molecule that behaves as an antagonist for Wnt signaling. Subsequent studies have shown that DKK-1 and DKK-4 play an important regulatory role in the Wnt /β-catenin signaling pathway by forming inhibitory complexes with LDL receptor-related proteins 5 and 6 (LRP5 and LRP6), which are essential components of the Wnt/βcatenin signaling system. LPR5 and LPR6 are single-pass transmembrane proteins that appear to act as co-receptors for Wnt ligands involved in the Wnt/βcatenin signaling cascade. It has been suggested that by inhibiting Wnt/β-catenin signaling, which is essential for posterior patterning in vertebrates, DKK-1 permits anterior development. This notion is supported by the finding that mice deficient of DKK-1 expression lack head formation and die during embryogenesis. Recombinant human DKK-1 expressed in human 293 cells is a 35-40 kDa glycoprotein containing 235 amino-acid residues.

Dkk-1 (Human) LumiAb ELISA Kit

MBS9510975-10x96StripWells 10x96-Strip-Wells
EUR 4355

Dkk-1 (Human) LumiAb ELISA Kit

MBS9510975-5x96StripWells 5x96-Strip-Wells
EUR 2225

Dkk-1 (Human) LumiAb ELISA Kit

MBS9510975-96StripWells 96-Strip-Wells
EUR 500

Dkk-1 (Human) Sandwich ELISA Kit

OK-0326 1Kit
EUR 280
Description: Dkk-1 (Human) Colorimetric Sandwich ELISA Kit

Dkk-1 (Human) OmniKine ELISA Kit

MBS9502047-1x96Wells 1x96Wells
EUR 500

Dkk-1 (Human) OmniKine ELISA Kit

MBS9502047-5x96Wells 5x96Wells
EUR 2300

Human DKK-1 PicoKine ELISA Kit

MBS176546-5x96StripWells 5x96-Strip-Wells
EUR 2755

Human DKK-1 PicoKine ELISA Kit

MBS176546-96StripWells 96-Strip-Wells
EUR 600

Human Dickkopf-1(Dkk-1) ELISA kit

E22-HC074.48 48T
EUR 495

Human Dickkopf-1(Dkk-1) ELISA kit

E22-HC074.96 96T
EUR 595

Human DKK Antibody

E63C02401 100ug/100ul
EUR 225
Description: Available in various conjugation types.

Human DKK Antibody

MBS857428-01mg 0.1mg
EUR 305

Human DKK Antibody

MBS857428-01mLAF405L 0.1mL(AF405L)
EUR 465

Human DKK Antibody

MBS857428-01mLAF405S 0.1mL(AF405S)
EUR 465

Human DKK Antibody

MBS857428-01mLAF610 0.1mL(AF610)
EUR 465

Human DKK Antibody

MBS857428-01mLAF635 0.1mL(AF635)
EUR 465

Human DKK-1 Recombinant Protein Lyophilized

IHUDKK1RLY2UG each
EUR 341
  • Wet Ice
Description: Human DKK-1 Recombinant Protein Lyophilized

Human DKK-1 Recombinant Protein Lyophilized

MBS8431839-INQUIRE INQUIRE Ask for price

Human DKK-1 ELISA kit (4×96T)

LF-EK50798 4×96T
EUR 2641.2

Nori® Human DKK-1 ELISA Kit

GR106268 96-well
EUR 461

Dkk-1

GT30000 50 ug
EUR 391.5

Dkk-1

MBS555901-005mg 0.05mg
EUR 610

Dkk-1

MBS555901-5x005mg 5x0.05mg
EUR 2590

OKAG00221-96W - Dkk-1 ELISA Kit (Human)

OKAG00221-96W 1plate:12x8-WellMicrostrips
EUR 475
  • Dkk-1 ELISA Kit (Human)

OKRC00363-96W - Dkk-1 ELISA Kit (Human)

OKRC00363-96W 96Wells
EUR 525
  • Dkk-1 ELISA Kit (Human)

Dkk-1, 32-266aa, Human, His tag, Baculovirus

MBS203274-001mg 0.01mg
EUR 375

Dkk-1, 32-266aa, Human, His tag, Baculovirus

MBS203274-005mg 0.05mg
EUR 1265

Dkk-1, 32-266aa, Human, His tag, Baculovirus

MBS203274-5x005mg 5x0.05mg
EUR 5460

Human DKK Antibody-HRP

E63C02402 100ug/100ul
EUR 275
Description: Available in various conjugation types.

Human DKK Antibody-HRP

MBS857208-01mg 0.1mg
EUR 345

Human DKK Antibody-HRP

MBS857208-5x01mg 5x0.1mg
EUR 1410

DKK-3 ELISA KIT|Human

EF000091 96 Tests
EUR 826.8

Human Dkk-4 ELISA Kit

NR-E10158
  • Ask for price
  • Ask for price
  • Ask for price
  • 96 Tests
  • 2x 96 Tests
  • 4x 96 Tests

Human Dkk-3 ELISA Kit

NR-E10157
  • Ask for price
  • Ask for price
  • 96 Tests
  • 96 Tests

Human Dkk-3 ELISA Kit

SEKH-0145
  • Ask for price
  • Ask for price
  • 48 Tests
  • 96 Tests

Recombinant Human DKK1 / Dkk-1 Protein (His tag)

MBS2546459-002mg 0.02mg
EUR 315

Recombinant Human DKK1 / Dkk-1 Protein (His tag)

MBS2546459-01mg 0.1mg
EUR 605

Recombinant Human DKK1 / Dkk-1 Protein (His tag)

MBS2546459-5x01mg 5x0.1mg
EUR 2715

Recombinant Human DKK1/Dkk-1 Protein (N-His)

MBS2557306-001mg 0.01mg
EUR 220

Recombinant Human DKK1/Dkk-1 Protein (N-His)

MBS2557306-005mg 0.05mg
EUR 505

Recombinant Human DKK1/Dkk-1 Protein (N-His)

MBS2557306-5x005mg 5x0.05mg
EUR 2270

Recombinant Human DKK1/Dkk-1 Protein (His Tag)

PKSH033697-10ug 10ug
EUR 178
  • > 95 % as determined by reducing SDS-PAGE.
Description: Human

Recombinant Human DKK1/Dkk-1 Protein (His Tag)

PKSH033697-50ug 50ug
EUR 523
  • > 95 % as determined by reducing SDS-PAGE.
Description: Human

Human DKK Antibody-BIOTIN

E63C02403 100ug/100ul
EUR 275
Description: Available in various conjugation types.

Human DKK Antibody-BIOTIN

MBS857030-01mg 0.1mg
EUR 345

Human DKK Antibody-BIOTIN

MBS857030-5x01mg 5x0.1mg
EUR 1410

Mouse anti Human DKK1/Dkk-1 Monoclonal Antibody

MBS2543267-006mL 0.06mL
EUR 250

Mouse anti Human DKK1/Dkk-1 Monoclonal Antibody

MBS2543267-012mL 0.12mL
EUR 370

Mouse anti Human DKK1/Dkk-1 Monoclonal Antibody

MBS2543267-02mL 0.2mL
EUR 550

Human Dkk-2 Recombinant Protein

200-014 20 µg
EUR 136.5
Description: The dickkopf (DKK)-related protein family is comprised of four central members, DKK-1 - 4, along with the distantly-related DKK family member DKK-11 (Soggy), which is thought to be a descendent of an ancestral DKK-3 precursor due to its unique sequence homology to DKK-3 and no other DKK family member. DKK family members, with the exception of the divergent Soggy, share two conserved cysteine-rich domains and show very little sequence similarity outside of these domains. Playing an important regulatory role in vertebrate development through localized inhibition of Wnt-regulated processes, including anterior-posterior axial patterning, limb development, somitogenesis, and eye formation, DKKs have also been implicated post-developmentally in bone formation, bone disease, cancer, and neurodegenerative diseases. DKK proteins typically play an important regulatory role in the Wnt/β-catenin signaling pathway by forming inhibitory complexes with LDL receptor-related proteins 5 and 6 (LRP5 and LRP6), which are essential components of the Wnt/β-catenin signaling system. LRP5 and LRP6 are single-pass transmembrane proteins that appear to act as co-receptors for Wnt ligands involved in the Wnt/β-catenin signaling cascade. DKK-2 has been shown to both inhibit and enhance canonical Wnt signaling; enhancing Wnt signaling through direct high-affinity binding of DKK-2 to LRP6 during LRP6 overexpression, while inhibiting Wnt signaling and promoting LRP6 internalization through the formation of a ternary complex between DKK-2, LRP6, and Kremen-2. Recombinant Human DKK-2 fused to a C terminal His-tag derived from E. coli has a molecular weight of 26.0 kDa and contains 234 amino acid residues.

Human Dkk-2 Recombinant Protein

200-014S 5 µg
EUR 92.4
Description: The dickkopf (DKK)-related protein family is comprised of four central members, DKK-1 - 4, along with the distantly-related DKK family member DKK-11 (Soggy), which is thought to be a descendent of an ancestral DKK-3 precursor due to its unique sequence homology to DKK-3 and no other DKK family member. DKK family members, with the exception of the divergent Soggy, share two conserved cysteine-rich domains and show very little sequence similarity outside of these domains. Playing an important regulatory role in vertebrate development through localized inhibition of Wnt-regulated processes, including anterior-posterior axial patterning, limb development, somitogenesis, and eye formation, DKKs have also been implicated post-developmentally in bone formation, bone disease, cancer, and neurodegenerative diseases. DKK proteins typically play an important regulatory role in the Wnt/β-catenin signaling pathway by forming inhibitory complexes with LDL receptor-related proteins 5 and 6 (LRP5 and LRP6), which are essential components of the Wnt/β-catenin signaling system. LRP5 and LRP6 are single-pass transmembrane proteins that appear to act as co-receptors for Wnt ligands involved in the Wnt/β-catenin signaling cascade. DKK-2 has been shown to both inhibit and enhance canonical Wnt signaling; enhancing Wnt signaling through direct high-affinity binding of DKK-2 to LRP6 during LRP6 overexpression, while inhibiting Wnt signaling and promoting LRP6 internalization through the formation of a ternary complex between DKK-2, LRP6, and Kremen-2. Recombinant Human DKK-2 fused to a C terminal His-tag derived from E. coli has a molecular weight of 26.0 kDa and contains 234 amino acid residues.

Human Dkk-3 Recombinant Protein

PROTQ9UBP4 Regular: 20ug
EUR 250
Description: Human Dkk-3 Recombinant Protein expressed in Baculovirus with His-tag. Sequence domain: 22-350aa. Application(s): SDS-PAGE. Endotoxin: < 1 EU per 1ug of protein (determined by LAL method).

Recombinant Human Dkk-3 Protein

RP00209 10 μg
EUR 38.26
  • Dkk-3, also known as REIC (Reduced Expansion in Immortalized Cells), is one of four numbered members of the Dickkopf family of Wnt antagonists . Dkk-3 is a secreted monomer expressed in many normal human tissues, most strongly in heart, brain and spi
  • Show more

Recombinant Human Dkk-3 Protein

RP00355 10 μg
EUR 41.8

human Dkk-3 Recombinant Protein

100-408 10 µg
EUR 196.35
Description: The dickkopf (DKK)-related protein family is comprised of four central members, DKK-1 - 4, along with the distantly-related DKK family member DKK-l1 (Soggy), which is thought to be a descendent of an ancestral DKK-3 precursor due to its unique sequence homology to DKK-3 and no other DKK family member. DKK family members, with the exception of the divergent Soggy, share two conserved cysteine-rich domains and show very little sequence similarity outside of these domains.  Playing an important regulatory role in vertebrate development through localized inhibition of Wnt regulated processes, including anterior-posterior axial patterning, limb development, somitogenesis, and eye formation, DKKs have also been implicated post-developmentally in bone formation, bone disease, cancer, and neurodegenerative diseases. DKK proteins typically play an important regulatory role in the Wnt /β-catenin signaling pathway by forming inhibitory complexes with LDL receptor-related proteins 5 and 6 (LRP5 and LRP6), which are essential components of the Wnt/β-catenin signaling system. LRP5 and LRP6 are single-pass transmembrane proteins that appear to act as co-receptors for Wnt ligands involved in the Wnt/β-catenin signaling cascade. DKK-3 has been shown to potentiate, rather than inhibit, Wnt signaling through interactions with the high-affinity, transmembrane coreceptors Kremen-1 (Krm1) and Kremen-2 (Krm2). Recombinant human DKK-3 expressed in CHO cells is a glycoprotein that has a calculated molecular weight of 36.3 kDa and contains 329 amino acid residues. Due to glycosylation, human DKK-3 migrates at an apparent molecular weight of approximately 39-49 kDa by SDS-PAGE analysis under non-reducing conditions.

human Dkk-3 Recombinant Protein

100-408S 2 µg
EUR 92.4
Description: The dickkopf (DKK)-related protein family is comprised of four central members, DKK-1 - 4, along with the distantly-related DKK family member DKK-l1 (Soggy), which is thought to be a descendent of an ancestral DKK-3 precursor due to its unique sequence homology to DKK-3 and no other DKK family member. DKK family members, with the exception of the divergent Soggy, share two conserved cysteine-rich domains and show very little sequence similarity outside of these domains.  Playing an important regulatory role in vertebrate development through localized inhibition of Wnt regulated processes, including anterior-posterior axial patterning, limb development, somitogenesis, and eye formation, DKKs have also been implicated post-developmentally in bone formation, bone disease, cancer, and neurodegenerative diseases. DKK proteins typically play an important regulatory role in the Wnt /β-catenin signaling pathway by forming inhibitory complexes with LDL receptor-related proteins 5 and 6 (LRP5 and LRP6), which are essential components of the Wnt/β-catenin signaling system. LRP5 and LRP6 are single-pass transmembrane proteins that appear to act as co-receptors for Wnt ligands involved in the Wnt/β-catenin signaling cascade. DKK-3 has been shown to potentiate, rather than inhibit, Wnt signaling through interactions with the high-affinity, transmembrane coreceptors Kremen-1 (Krm1) and Kremen-2 (Krm2). Recombinant human DKK-3 expressed in CHO cells is a glycoprotein that has a calculated molecular weight of 36.3 kDa and contains 329 amino acid residues. Due to glycosylation, human DKK-3 migrates at an apparent molecular weight of approximately 39-49 kDa by SDS-PAGE analysis under non-reducing conditions.

 

 

Tags: , , , , , , , , , , , , , , , , , , , , , , ,